GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SIGA Technologies Inc (NAS:SIGA) » Definitions » Cyclically Adjusted PS Ratio

SIGA Technologies (SIGA Technologies) Cyclically Adjusted PS Ratio : 5.67 (As of Apr. 30, 2024)


View and export this data going back to 1997. Start your Free Trial

What is SIGA Technologies Cyclically Adjusted PS Ratio?

As of today (2024-04-30), SIGA Technologies's current share price is $8.79. SIGA Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $1.55. SIGA Technologies's Cyclically Adjusted PS Ratio for today is 5.67.

The historical rank and industry rank for SIGA Technologies's Cyclically Adjusted PS Ratio or its related term are showing as below:

SIGA' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.29   Med: 7.34   Max: 35.87
Current: 5.7

During the past years, SIGA Technologies's highest Cyclically Adjusted PS Ratio was 35.87. The lowest was 1.29. And the median was 7.34.

SIGA's Cyclically Adjusted PS Ratio is ranked worse than
83.09% of 739 companies
in the Drug Manufacturers industry
Industry Median: 2.09 vs SIGA: 5.70

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

SIGA Technologies's adjusted revenue per share data for the three months ended in Dec. 2023 was $1.610. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $1.55 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


SIGA Technologies Cyclically Adjusted PS Ratio Historical Data

The historical data trend for SIGA Technologies's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SIGA Technologies Cyclically Adjusted PS Ratio Chart

SIGA Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.01 7.97 6.69 5.55 3.61

SIGA Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.55 4.24 3.67 3.76 3.61

Competitive Comparison of SIGA Technologies's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, SIGA Technologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SIGA Technologies's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SIGA Technologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where SIGA Technologies's Cyclically Adjusted PS Ratio falls into.



SIGA Technologies Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

SIGA Technologies's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=8.79/1.55
=5.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SIGA Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, SIGA Technologies's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.61/129.4194*129.4194
=1.610

Current CPI (Dec. 2023) = 129.4194.

SIGA Technologies Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.010 99.695 0.013
201406 0.012 100.560 0.015
201409 0.021 100.428 0.027
201412 0.016 99.070 0.021
201503 0.022 99.621 0.029
201506 0.027 100.684 0.035
201509 0.025 100.392 0.032
201512 0.077 99.792 0.100
201603 0.023 100.470 0.030
201606 0.035 101.688 0.045
201609 0.086 101.861 0.109
201612 0.108 101.863 0.137
201703 0.066 102.862 0.083
201706 0.054 103.349 0.068
201709 0.018 104.136 0.022
201712 0.018 104.011 0.022
201803 0.022 105.290 0.027
201806 0.033 106.317 0.040
201809 5.680 106.507 6.902
201812 0.019 105.998 0.023
201903 0.127 107.251 0.153
201906 0.048 108.070 0.057
201909 0.099 108.329 0.118
201912 0.052 108.420 0.062
202003 0.032 108.902 0.038
202006 0.501 108.767 0.596
202009 0.566 109.815 0.667
202012 0.486 109.897 0.572
202103 0.062 111.754 0.072
202106 0.113 114.631 0.128
202109 0.065 115.734 0.073
202112 1.524 117.630 1.677
202203 0.143 121.301 0.153
202206 0.227 125.017 0.235
202209 0.986 125.227 1.019
202212 0.155 125.222 0.160
202303 0.115 127.348 0.117
202306 0.083 128.729 0.083
202309 0.130 129.860 0.130
202312 1.610 129.419 1.610

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


SIGA Technologies  (NAS:SIGA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


SIGA Technologies Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of SIGA Technologies's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SIGA Technologies (SIGA Technologies) Business Description

Traded in Other Exchanges
N/A
Address
31 East 62nd Street, New York, NY, USA, 10065
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus.
Executives
Evan A. Knisely director C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Jay Varma director C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Ford Harold Eugene Jr. director 4921 WILLIAM ARNOLD ROAD, MEMPHIS TN 38117
James Antal director 30952 STEEPLECHASE DRIVE, SAN JUAN CAPISTRANO CA 92675
Holly L. Phillips director C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Gary J. Nabel director C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Julian Nemirovsky director 35 EAST 62ND STREET, NEW YORK NY 10065
Edward P. Taibi director 35 EAST 62ND STREET, NEW YORK NY 10065
Jaymie A Durnan director C/O SIGA TECHNOLOGIES, INC.,, 31 EAST 62ND STREET, NEW YORK NY 10065
Gomez Phillip Louis Iii officer: Chief Executive Officer 7220 VAN NESS COURT, MCLEAN VA 22101
Daniel J Luckshire officer: Executive VP & CFO C/O SIGA TECHNOLOGIES, INC., 35 EAST 62ND STREET, NEW YORK NY 10065
Paul G Savas director 35 EAST 62ND STREET, NEW YORK NY 10021
Julie Kane director 77 BEALE ST, P.O. BOX 770000, SAN FRANCISCO CA 94177
Dennis E Hruby officer: Chief Scientific Officer SIGA TECHNOLOGIES, INC., 420 LEXINGTON AVENUE, SUITE 601, NEW YORK NY 10170
Michael J Bayer director 1100 N GLEBE ROAD, ARLINGTON VA 22201

SIGA Technologies (SIGA Technologies) Headlines

From GuruFocus

SIGA Provides Update on Progress in Clinical Trials to Assess Use of TPOXX � (tecovirimat) for Treatment of Monkeypox

By deactivated_deactivated_Ds*** deactivated_deactivated_Ds*** 10-12-2022

SIGA Technologies Receives Approval from UK for Tecovirimat

By GuruFocusNews GuruFocusNews 07-08-2022